147245-29-2Relevant academic research and scientific papers
INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES
-
Paragraph 00944-00946, (2021/12/28)
Provided herein are heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
METALLOENZYME INHIBITOR COMPOUNDS
-
Page/Page column 50, (2020/07/25)
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
METALLOENZYME INHIBITOR COMPOUNDS
-
Paragraph 0327; 0328; 0329; 0330, (2018/07/29)
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
Specific features of nucleophilic substitution in 1-chloro-3,4- dinitrobenzene
Zotova,Kushakova,Kuznetsov,Rodin,Garabadzhiu
, p. 1473 - 1476 (2007/10/03)
Effects of the solvent, temperature, and nucleophile nature on the selectivity of nucleophilic substitution in 1-chloro-3,4-dinitrobenzene were studied, and optimal conditions were found for the synthesis and isolation of particular products.
